Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combination pharmaceutical agents as RSV inhibitors

US Patent 10881666 · Granted Jan 5, 2021

Estimated economic value: $8,778,000

Assignee

Inventors

View full patent text on Google Patents →